SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for VVOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 33.70M
March 31, 2026 33.10M
December 31, 2025 29.13M
September 30, 2025 24.96M
June 30, 2025 21.51M
March 31, 2025 19.28M
December 31, 2024 19.61M
September 30, 2024 20.92M
June 30, 2024 21.33M
March 31, 2024 23.35M
December 31, 2023 24.94M
September 30, 2023 27.15M
June 30, 2023 29.64M
March 31, 2023 32.56M
Date Value
December 31, 2022 34.42M
September 30, 2022 35.59M
June 30, 2022 36.35M
March 31, 2022 34.45M
December 31, 2021 31.34M
September 30, 2021 27.33M
June 30, 2021 23.06M
March 31, 2021 20.36M
December 31, 2020 18.98M
September 30, 2020 18.98M
March 31, 2020 14.76M
December 31, 2019 9.968M
September 30, 2019 5.430M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Hinge Health, Inc. 385.66M
Exlites Holdings International, Inc. 0.1111M
Xcelerate, Inc. 0.0698M
Haemonetics Corp. 451.54M
Pro-Dex, Inc. 5.452M